Skip to main content

WELLS FARGO & COMPANY/MN

Position in DYN — Dyne Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in DYN

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$2,638,076
-$253,498 QoQ
Shares Held
145,509
-1.6% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 99.25159268498855.ToString("F0")% Shared 0.ToString("F0")% None 0.7484073150114426.ToString("F0")%

Common Shares in DYN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. DYN ranks #56 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DYN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,638,076 145,509
2025-12-31 $2,891,574 147,831
2025-09-30 $1,102,080 87,121
2025-06-30 $539,831 56,705
2025-03-31 $420,052 40,158
2024-12-31 $913,044 38,754
2024-09-30 $900,765 25,077
2024-06-30 $919,657 26,060
2024-03-31 $566,579 19,957
2023-12-31 $173,285 13,029
2023-09-30 $315,804 35,246
2023-06-30 $408,555 36,316
2023-03-31 $67,356 5,847
2022-09-30 $520 41
2022-06-30 $2,445 356
2022-03-31 $13,235 1,373
2021-12-31 $143,214 12,045
2021-06-30 $6,795 323
2021-03-31 $78,410 5,049
2020-12-31 $155,169 7,389